Skip to main content

DSM Capital Partners LLC

SEC CIK
0001214639
Latest filing
Aug 3, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by DSM Capital Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
511,968
Value
$21.9M
% of portfolio
0.4%
Quarters held
20
Since Q1 2021
Holdings of BSX by DSM Capital Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026511,968$21.9M0.4%−52,381−9.3%ReducedHolders
Q1 2026564,349$35.4M0.6%+559,625+11,846.4%AddedHolders
Q4 20254,724$450.4K<0.1%+747+18.8%AddedHolders
Q3 20253,977$388.3K<0.1%+1,119+39.2%AddedHolders
Q2 20252,858$307.0K<0.1%+2,858NewHolders
Q4 20240$00.0%−1,324−100.0%Sold outHolders
Q3 20241,324$111.0K<0.1%00.0%UnchangedHolders
Q2 20241,324$102.0K<0.1%−2,167,681−99.9%ReducedHolders
Q1 20242,169,005$148.6M2.0%−669,618−23.6%ReducedHolders
Q4 20232,838,623$164.1M2.5%+444,794+18.6%AddedHolders
Q3 20232,393,829$126.4M2.1%−96,116−3.9%ReducedHolders
Q2 20232,489,945$134.7M2.2%−1,162,600−31.8%ReducedHolders
Q1 20233,652,545$182.7M3.0%−1,347,768−27.0%ReducedHolders
Q4 20225,000,313$231.4M3.8%−590,902−10.6%ReducedHolders
Q3 20225,591,215$216.5M3.7%+294,050+5.6%AddedHolders
Q2 20225,297,165$197.4M3.3%+268,026+5.3%AddedHolders
Q1 20225,029,139$222.7M3.0%+1,174,491+30.5%AddedHolders
Q4 20213,854,648$163.7M1.7%−271,157−6.6%ReducedHolders
Q3 20214,125,805$179.1M1.9%+501,060+13.8%AddedHolders
Q2 20213,624,745$155.0M1.5%+465,847+14.7%AddedHolders
Q1 20213,158,898$122.1M1.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.